← Eichor
Study identifier: NCT01016613 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Clinical Phenotyping Resource and Biobank Core of the Michigan O'Brien Renal Center

Condition: Chronic Kidney Disease · Glomerulopathy  ·  Sponsor: University of Michigan

PhaseN/A
Planned participants1800
Who can joinAll sexes, N/A to no upper limit
Healthy volunteersYes

About this study

Chronic kidney disease (CKD) affects approximately 26 million Americans and disproportionately manifests in specific race and ethnic groups. Patients burdened with CKD have significant morbidity and reduced life expectancy. In addition to excessive suffering and lost productivity, the cost of managing this epidemic has reached $40 billion annually. The recognition that CKD is a major public health problem is reflected in the fourteen objectives outlined in Healthy People 2020 to begin to address the disease burden. Advancement in approaches to halt CKD progression has been slow despite growing global awareness of disease burden. This O'Brien Kidney Research Core will create opportunities for novel insights through characterization of tissue profiles that will define new disease markers and molecular pathways and will be available to all kidney investigators on the www. It will thereby fundamentally alter the starting point for research into prevention of progression of these kidney diseases. C-PROBE is an essential element of the center grant and presents a biomedical resource core consisting of: (1) clinical phenotyping (that is, systematic identification of observable physical and biomedical characteristics) of kidney disease patients including the accurate measurement of kidney function; and (2) a specimen BioBank which will store blood, urine and kidney tissue samples. A key component of C-PROBE is therefore that it contains a proven mechanism to collect samples from hig…

This description comes directly from the study's public registry record.

Talk to the study team

Chrysta Lienczewski  ·  734-615-5021  ·  boridley@med.umich.edu

Markus Bitzer, MD  ·  734-763-4688  ·  markusbi@med.umich.edu

Always discuss trial participation with your own doctor first.

Locations (5)

University of Michigan Health SystemAnn Arbor, Michigan, United StatesRecruiting
Wayne State UniversityDetroit, Michigan, United StatesCompleted
St. John's Health SystemDetroit, Michigan, United StatesCompleted
Levine Children's HospitalCharlotte, North Carolina, United StatesCompleted
Temple UniversityPhiladelphia, Pennsylvania, United StatesCompleted

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT01016613